3-{[(3-chlorophenyl)methyl]sulfanyl}-5-methyl-1,2-thiazole-4-carbonitrile

Catalog No.: 
ACOJPZ091
CAS No.: 
338778-17-9
Molecular Formula: 
C12H9ClN2S2
Molecular Weight: 
280.80
3-{[(3-chlorophenyl)methyl]sulfanyl}-5-methyl-1,2-thiazole-4-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$936.00InquiryInquiry
1g90%$2922.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-{[(3-chlorophenyl)methyl]sulfanyl}-5-methyl-1,2-thiazole-4-carbonitrile
IUPAC Name3-((3-chlorobenzyl)thio)-5-methylisothiazole-4-carbonitrile
MDL No.MFCD00138525
Molecular FormulaC12H9ClN2S2
Molecular Weight280.80
SMILESN#CC1=C(C)SN=C1SCC2=CC=CC(Cl)=C2
InChI KeyBDQGOHFFIGOPOZ-UHFFFAOYSA-N
Synonym3-[(3-CHLOROBENZYL)SULFANYL]-5-METHYL-4-ISOTHIAZOLECARBONITRILE;4-Isothiazolecarbonitrile, 3-[[(3-chlorophenyl)methyl]thio]-5-methyl-;3-((3-Chlorobenzyl)thio)-5-methylisothiazole-4-carbonitrile
CAS No.338778-17-9

Synthetic Route by SureRoute

1. ACOJPZ091 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBSID954 route compound structure diagram
    ACBSID95425697-57-8In Stock
  4. Then
  5. ACOJPZ091 route product structure diagram
    ACOJPZ091338778-17-9
Inquiry

2. ACOJPZ091 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOJPZ091 route product structure diagram
    ACOJPZ091338778-17-9
Inquiry

3. ACOJPZ091 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOJPZ091 route product structure diagram
    ACOJPZ091338778-17-9
Inquiry

Comments (0)